Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLAG Antikörper (C-Term)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch HLAG in FACS, WB, IHC (fro), IHC (p), IF, EIA und ELISA (Capture). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN238372

Kurzübersicht für HLAG Antikörper (C-Term) (ABIN238372)

Target

Alle HLAG Antikörper anzeigen
HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

Reaktivität

  • 158
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 107
  • 56
  • 3
  • 1
  • 1
Maus

Klonalität

  • 110
  • 58
Monoklonal

Konjugat

  • 107
  • 18
  • 15
  • 11
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser HLAG Antikörper ist unkonjugiert

Applikation

  • 100
  • 73
  • 65
  • 53
  • 27
  • 23
  • 16
  • 12
  • 10
  • 8
  • 6
  • 6
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Enzyme Immunoassay (EIA), ELISA (Capture)

Klon

5A6G7
  • Bindungsspezifität

    • 11
    • 8
    • 6
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Spezifität

    The antibody 5A6G7 allows to discriminate between soluble HLA-G protein yielded by shedding from membrane-bound HLA-G forms that do not contain the intron 4-encoded epitope and soluble HLA-G5/HLA-G6 produced from intron 4-retaining alternatively spliced mRNAs. HLA-G belongs to the MHC Class I molecules (MHC Class Ib, nonclassical) and it is expressed on the surface of trophoblast cells.

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Produktmerkmale

    Synonyms: HLA-6.0, HLAG, MHC class I antigen G, HLA class I histocompatibility antigen

    Aufreinigung

    Protein A chromatography

    Immunogen

    C-terminal amino acid sequence (22-mer) of soluble HLA-G5 and HLA-G6 proteins coupledto ovalbumin.

    Isotyp

    IgG1
  • Applikationshinweise

    Western Blotting (Reducing Conditions): 12 % AA SDS-PAGE. Positive Control: JEG-3 cell lysate. Flow Cytometry. Immunohistochemistry on Paraffin and Frozen Sections: 10-20 μg/mL. Positive tissue: placenta tissue. Immunocytochemistry. ELISA: The antibody 5A6G7 has been tested as the capture antibody in a sandwich ELISAfor analysis of soluble HLA-G in combination with antibody ABIN238525. Positive Control: HeLa/HLA-G5 transfectants cell lysate. HeLa/HLA-G5 cell supernatant. Negative Control: HeLa cell lysate.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    PBS, pH 7.4 with 15 mM Sodium Azide as preservative

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.

    Haltbarkeit

    12 months
  • Target

    HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

    Andere Bezeichnung

    HLA Class I alpha G / HLA-G

    Hintergrund

    HLA G belongs to the HLA class I heavy chain paralogues. It is a heterodimer consisting of a heavy chain (with a1, a2, a3 domains) and a light chain (beta 2 microglobulin). Alternate splicing provides both soluble and membrane bound forms of HLA G, with two soluble isoforms and four membrane bound isoforms. HLA G may be part of the fetal protection system and is expressed on fetal derived placental cells.Synonyms: HLA class I histocompatibility antigen, HLA-6.0, HLAG, MHC class I antigen G

    Gen-ID

    3135

    UniProt

    P17693

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!